Many approaches have been developed and are being under investigation to prevent and treat acute GVHD using experimental models, including IL-21 blockade, Histone deacetylase inhibitors inducible costimulator, CSF-1, glycogen synthase kinase 3 inhibotion, Human CD8+ Regulatory T Cells [131–137]. This evidence concerns the gene CD8A and acute graft versus host disease.